Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$59.21 - $92.9 $10,302 - $16,164
174 Added 47.8%
538 $49,000
Q4 2023

Feb 07, 2024

BUY
$37.55 - $62.64 $13,668 - $22,800
364 New
364 $22,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Arcadia Investment Management Corp Portfolio

Follow Arcadia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.